SCAN-HF study

SCAN-HF study - SCAN-HF study: Risk Stratification by Integrated DiagNostics in Patients With Heart Failure

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009522

Enrollment

320

Registered

2012-12-12

Start date

2013-03-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patient has CRT-D indications in Japan. 2. Patient scheduled to be implanted or who has already implanted with CRT-D with OptiVol2.0 within 65 days. 3. Patient has a history of at least one heart failure related hospitalization, or all visit necessitating intravenous diuretic, inotropic, vasodilator, or other parenteral therapy for heart failure within 12 months prior to baseline evaluation. 4. Patient is 20 years of age or older. 5. Patient is willing and able to comply with the protocol. 6. Patient is able to provide an informed consent to be part of the study.

Exclusion criteria

Exclusion criteria: 1. Patients with life expectancy of less than 15 months. 2. Patients enrolled in a concurrent study that may confound the results of the study.

Design outcomes

Primary

Measure	Time frame
Heart Failure Hospitalization	—

Countries

Japan

Contacts

Public ContactKazuhiro Hidaka

Medtronic Japan Co., Ltd. Post Market Clinical Research Department, Post Market, Clinical Affairs

kazuhiro.hidaka@medtronic.com03-6776-0055

Outcome results